
A study assessed outcomes and safety of a single-step method using scaffolds (fibrin glues, collagen gels, collagen-hydroxyapatite membrane) and filtered Bone Marrow Aspirate (fBMA) for osteochondral lesions of the talus (OLTs). A study of 35 patients (ages 16–55, ≥1 year follow-up) analyzed Patient-reported outcome measures (PROMs), serious adverse events (SAE), graft failures (GF), and cellular parameters. After 32.2 months, results showed significant improvement in Foot and Ankle Outcome Scores and European Quality of Life. Negative predictors included female gender and concomitant procedures. Cellular parameters, particularly fibroblast colony forming units, correlated positively with improvements. The study supports scaffolds augmented with fBMA as a safe and effective osteochondral lesion of the talus (OLTs) treatment.
Like
Save
Share